Publications

• Depression in Individuals with Epilepsy.
  Barry, J. J., Huynh, N., & Lembke, A. (2000). Depression in Individuals with Epilepsy. Current Treatment Options in Neurology, 2(6), 571–585.
• Impaired recognition of facial emotion in mania
  Lembke, A., & Ketter, T. A. (2002). Impaired recognition of facial emotion in mania. AMERICAN JOURNAL OF PSYCHIATRY, 159(2), 302–4.
• Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders
  Janenawasin, S., Wang, P. W., Lembke, A., Schumacher, M., Das, B., Santosa, C. M., … Ketter, T. A. (2002). Olanzapine in diverse syndromal and subsyndromal exacerbations of bipolar disorders. BIPOLAR DISORDERS, 4(5), 328–34.
• Neural correlates of timbre change in harmonic sounds Menon, V., Levitin, D. J., Smith, B. K., Lembke, A., Krasnow, B. D., Glazer, D., … McAdams, S. (2002). Neural correlates of timbre change in harmonic sounds. NEUROIMAGE, 17(4), 1742–1754.
  
• Safety of antidepressants in the elderly. Sommer, B. R., Fenn, H., Pompei, P., DeBattista, C., Lembke, A., Wang, P., & Flores, B. (2003). Safety of antidepressants in the elderly. Expert Opinion on Drug Safety, 2(4), 367–83.
  
• A Friday in the life of an academic psychiatrist Lembke, A. (2003). A Friday in the life of an academic psychiatrist. ACADEMIC PSYCHIATRY, 27(3), 214–15.
  
• A prospective trial of modafinil as an adjunctive treatment of major depression DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004). A prospective trial of modafinil as an adjunctive treatment of major depression. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 24(1), 87–90.
  
• Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices Barry, J. J., Lembke, A., & Bullock, K. D. (2004). Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: Drugs and devices. CLINICAL EEG AND NEUROSCIENCE, 35(1), 4–13.
  
• Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Lembke, A., Miklowitz, D. J., Otto, M. W., Zhang, H., Wisniewski, S. R., Sachs, G. S., … Ketter, T. A. (2004). Psychosocial service utilization by patients with bipolar disorders: data from the first 500 participants in the Systematic Treatment Enhancement Program. Journal of Psychiatric Practice, 10(2), 81–87.
  
• Why is this special issue on women's professional development in psychiatry necessary? Lembke, A. (2004). Why is this special issue on women's professional development in psychiatry necessary? ACADEMIC PSYCHIATRY, 28(4), 275–77.
  
• Update on augmentation of antidepressant response in resistant depression. DeBattista, C., & Lembke, A. (2005). Update on augmentation of antidepressant response in resistant depression. Current Psychiatry Reports, 7(6), 435–40.
  
• Depression and smoking cessation: does the evidence support psychiatric practice? Lembke, A., Johnson, K., & DeBattista, C. (2007). Depression and smoking cessation: does the evidence support psychiatric practice? Neuropsychiatric Disease and Treatment, 3(4), 487–93.
  
• Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization Lembke, A., Bradley, K. A., Henderson, P., Moos, R., & Harris, A. H. S. (2011). Alcohol Screening Scores and the Risk of New-Onset Gastrointestinal Illness or Related Hospitalization. JOURNAL OF GENERAL INTERNAL MEDICINE, 26(7), 777–82.
  
• The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression Lembke, A., Gomez, R., Tenakoon, L., Keller, J., Cohen, G., Williams, G. H., … Schatzberg, A. F. (2013). The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. PSYCHONEUROENDOCRINOLOGY, 38(1), 115–21.
  
• Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders Lembke, A. (2012). Time to Abandon the Self-Medication Hypothesis in Patients with Psychiatric Disorders. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 38(6), 524–29.
  
• Why Doctors Prescribe Opioids to Known Opioid Abusers Lembke, A. (2012). Why Doctors Prescribe Opioids to Known Opioid Abusers. NEW ENGLAND JOURNAL OF MEDICINE, 367(17), 1580–81.
  
• Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. Psychiatry Research, 211(2), 119–26.
  
• From self-medication to intoxication: time for a paradigm shift. Lembke, A. (2013). From self-medication to intoxication: time for a paradigm shift. Addiction , 108(4), 670–71.
  
• Isolated meningeal vasculopathy associated with Clostridium septicum infection Crowley, R. S., Lembke, A., & Horoupian, D. S. (1997). Isolated meningeal vasculopathy associated with Clostridium septicum infection. NEUROLOGY, 48(1), 265–267.
  
• The status of evidence-based guidelines and algorithms in the treatment of depression Debattista, C., Trivedi, M. H., Kern, J. K., & Lembke, A. (2002). The status of evidence-based guidelines and algorithms in the treatment of depression. PSYCHIATRIC ANNALS, 32(11), 658–663.
  
• Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder Miklowitz, D. J., Otto, M. W., Wisniewski, S. R., Araga, M., Frank, E., Reilly-Harrington, N. A., … Sachs, G. S. (2006). Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. PSYCHIATRIC SERVICES, 57(7), 959–965.
  
• The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression Che, A. M., Gomez, R. G., Keller, J., Lembke, A., Tennakoon, L., Cohen, G. H., & Schatzberg, A. F. (2012). The relationships of positive and negative symptoms with neuropsychological functioning and their ability to predict verbal memory in psychotic major depression. PSYCHIATRY RESEARCH, 198(1), 34–38.
  
• Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. Lembke, A. (2013). Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. Minnesota Medicine, 96(3), 36–37.
  
• HPA axis genetic variation, cortisol and psychosis in major depression. Schatzberg, A. F., Keller, J., Tennakoon, L., Lembke, A., Williams, G., Kraemer, F. B., … Murphy, G. M. (2014). HPA axis genetic variation, cortisol and psychosis in major depression. Molecular Psychiatry, 19(2), 220–27.
  
• Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Yuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., … Parker, K. J. (2014). Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. Journal of Psychiatric Research, 51, 30–36.
  
• Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers Harris, A. H. S., Ellerbe, L., Reeder, R. N., Bowe, T., Gordon, A. J., Hagedorn, H., … Trafton, J. A. (2013). Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Veterans Health Administration Service Providers. PSYCHOLOGICAL SERVICES, 10(4), 410–19.
  
• Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression Kelley, R., Garrett, A., Cohen, J., Gomez, R., Lembke, A., Keller, J., … Schatzberg, A. (2013). Altered brain function underlying verbal memory encoding and retrieval in psychotic major depression. PSYCHIATRY RESEARCH-NEUROIMAGING, 211(2), 119–26.
  
• Recovery-oriented policy and care systems in the UK and USA. Humphreys, K., & Lembke, A. (2014). Recovery-oriented policy and care systems in the UK and USA. Drug and Alcohol Review, 33(1), 13–18.
  
• Clinical management of alcohol use disorders in the neurology clinic. Lembke, A., & Stanford, M. (2014). Clinical management of alcohol use disorders in the neurology clinic. Handbook of Clinical Neurology, 125, 659–70.
  
• Assessment of provider attitudes toward #naloxone on Twitter. Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward #naloxone on Twitter. Substance Abuse, 37(1), 35–41.
  
• A qualitative study of treatment-seeking heroin users in contemporary China. Lembke, A., & Zhang, N. (2015). A qualitative study of treatment-seeking heroin users in contemporary China. Addiction Science & Clinical Practice, 10, 23-?
  
• Weighing the Risks and Benefits of Chronic Opioid Therapy Lembke, A., Humphreys, K., & Newmark, J. (2016). Weighing the Risks and Benefits of Chronic Opioid Therapy. AMERICAN FAMILY PHYSICIAN, 93(12), 982–90.
  
• Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. Leyro, T. M., Crew, E. E., Bryson, S. W., Lembke, A., Bailey, S. R., Prochaska, J. J., … David, S. P. (2016). Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open, 6(6).
  
• HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., & Schatzberg, A. F. (2016). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry.
  
• Use of Opioid Agonist Therapy for Medicare Patients in 2013. Lembke, A., & Chen, J. H. (2016). Use of Opioid Agonist Therapy for Medicare Patients in 2013. JAMA Psychiatry, 73(9), 990–92.
  
• Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Stein, M. D., Kanabar, M., Anderson, B. J., Lembke, A., & Bailey, G. L. (2016). Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Journal of Substance Abuse Treatment, 68, 57–61.
  
• Extended treatment for cigarette smoking cessation: A randomized control trial. Laude, J. R., Bailey, S. R., Crew, E., Varady, A., Lembke, A., McFall, D., … David, S. P. (2017). Extended treatment for cigarette smoking cessation: A randomized control trial. Addiction .
  
• A Day in the Life of an Academic Psychiatrist. Riba, M. B., Veith, R. C., Brodkey, A. C., Dimsdale, J. E., Zima, B. T., Stotland, N. L., … Arboleda-Flórez, J. (2003). A Day in the Life of an Academic Psychiatrist. Academic Psychiatry , 27(3), 187–224.
  
• HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., urphy, G. M., & Schatzberg, A. F. (2017). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. MOLECULAR PSYCHIATRY, 22(4), 527–36.
  
• The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine Lembke, A., & Humphreys, K. (2018). The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. ACADEMIC PSYCHIATRY, 42(2), 269–72.
  
• Our Other Prescription Drug Problem Lembke, A., Papac, J., & Humphreys, K. (2018). Our Other Prescription Drug Problem. NEW ENGLAND JOURNAL OF MEDICINE, 378(8), 693–95.
  
• Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Harrison, T. K., Kornfeld, H., Aggarwal, A. K., & Lembke, A. (2018). Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Anesthesiology Clinics, 36(3), 345–59.
  
• Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum Raber, I., Ball, A., Papac, J., Aggarwal, A., Sussman, R., Basaviah, P., … Lembke, A. (2018). Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum. Academic Psychiatry , 664–67.
  
• Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. Raheemullah, A., & Lembke, A. (2019). Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. JAMA Internal Medicine.
  
• Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. Lembke, A., Ottestad, E., & Schmiesing, C. (2019). Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. Pain Medicine (Malden, Mass.), 20(3), 425–28.
  
• Distribution of Opioids by Different Types of Medicare Prescribers. Chen, J. H., Humphreys, K., Shah, N. H., & Lembke, A. (2016). Distribution of Opioids by Different Types of Medicare Prescribers. JAMA Internal Medicine, 176(2), 259–61.
  
• Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum. Raber, I., Ball, A., Papac, J., Aggarwal, A., Sussman, R., Basaviah, P., … Lembke, A. (2018). Qualitative Assessment of Clerkship Students' Perspectives of the Topics of Pain and Addiction in their Preclinical Curriculum. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 42(5), 664–67.
  
• Tapering Patients Off of Benzodiazepines. Ogbonna, C. I., & Lembke, A. (2017). Tapering Patients Off of Benzodiazepines. American Family Physician, 96(9), 606–10.
  
• A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Lembke, A., & Humphreys, K. (2016). A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research. Tobacco Control, 25(3), 261–62.
  
• Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period Lembke, A., Ottestad, E., & Schmiesing, C. (2019). Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. PAIN MEDICINE, 20(3), 425–28.
  
• Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine. Chou, R., Ballantyne, J., & Lembke, A. (2019). Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine. Annals of Internal Medicine.
  
• Patterns of Opioid and Benzodiazepine Use in Opioid-Naive Patients with Newly Diagnosed Low Back and Lower Extremity Pain. Azad, T. D., Zhang, Y., Stienen, M. N., Vail, D., Bentley, J. P., Ho, A. L., … Ratliff, J. K. (2019). Patterns of Opioid and Benzodiazepine Use in Opioid-Naive Patients with Newly Diagnosed Low Back and Lower Extremity Pain. Journal of General Internal Medicine.
  
• Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. Raheemullah, A., & Lembke, A. (2019). Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. American Journal of Therapeutics.
  
• Tapering Long-Term Opioid Therapy. Lembke, A. (2020). Tapering Long-Term Opioid Therapy. American Family Physician, 101(1), 49–52.
  
• Tapering Long-Term Opioid Therapy Lembke, A. (2020). Tapering Long-Term Opioid Therapy. AMERICAN FAMILY PHYSICIAN, 101(1), 49–52.
  
• Substance Use Among Older Adults: Ethical Issues. Ogbonna, C. I., & Lembke, A. (2019). Substance Use Among Older Adults: Ethical Issues. Focus (American Psychiatric Publishing), 17(2), 143–47.
  
• Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence. Chou, R., Ballantyne, J., & Lembke, A. (2020). Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence. Annals of Internal Medicine, 172(4), 294.
  
• Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence Chou, R., Ballantyne, J., & Lembke, A. (2020). Buprenorphine for Long-Term Chronic Pain Management: Still Looking for the Evidence. ANNALS OF INTERNAL MEDICINE, 172(4), 294.
  
• Online mutual-help intervention for reducing heavy alcohol use. Haug, N. A., Morimoto, E. E., & Lembke, A. (2020). Online mutual-help intervention for reducing heavy alcohol use. Journal of Addictive Diseases, 1–9.